Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group (Q74789046)
Jump to navigation
Jump to search
scientific article published on 01 July 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group |
scientific article published on 01 July 1998 |
Statements
Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group (English)
Kern W
Behre G
Rudolf T
Kerkhoff A
Grote-Metke A
Eimermacher H
Kubica U
Wörmann B
Büchner T